Fresenius Medical Care AG & Co. KGaA Logo

Fresenius Medical Care AG & Co. KGaA

ISIN

DE0005785802

Ticker

FME

Sector

Health Care

Sub-Industry

Health Care Facilities

Country

Germany

Year Founded

1996

About Fresenius Medical Care AG & Co. KGaA

Company Description

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.8 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,171 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 345,000 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the Renal Care Continuum, the Company focuses on expanding in complementary areas and in the field of critical care. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).

Headcount

123,000

Served Area

Worldwide

Headquarters

Else-Kröner-Straße 1
61352, Bad Homburg v. d. Höhe
Germany

Filings & Publications

  • Consolidated Report 2022 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2022 - Q1 English πŸ‡¬πŸ‡§
  • Company Presentation 2022 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q2 English πŸ‡¬πŸ‡§
  • Company Presentation 2022 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q3 English πŸ‡¬πŸ‡§
  • Company Presentation 2022 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q4 English πŸ‡¬πŸ‡§
  • Company Presentation 2022 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q4 German πŸ‡©πŸ‡ͺ

Insider Trades

Date Trading entity / Person Association Trade type Volume
15.12.2023 Mazur-HofsÀß, Dr. Katarzyna Board Buy EUR 42,342.17
15.12.2023 Mazur-HofsÀß, Dr. Katarzyna Board Buy EUR 15,043.50
15.12.2023 Mazur-HofsÀß, Dr. Katarzyna Board Buy EUR 4,823.75
15.12.2023 Mazur-HofsÀß, Dr. Katarzyna Board Buy EUR 3,693.12
06.12.2023 Valle, William Board Other EUR 366,225.00
06.12.2023 Pring Giza, Helen Board Other EUR 264,360.84
06.12.2023 Maddux, Franklin W. Board Other EUR 246,309.94
06.12.2023 Mazur-HofsÀß, Dr. Katarzyna Board Other EUR 198,714.19
21.03.2023 Mazur-HofsÀß, Dr. Katarzyna Board Buy EUR 11,199.36
21.03.2023 Mazur-HofsÀß, Dr. Katarzyna Board Buy EUR 10,933.84

Capital Markets Information

ISIN

DE0005785802

LEI

549300CP8NY40UP89Q40

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Facilities

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

MDAX

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.